A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2011
11/03/2011	US20110269791 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
11/03/2011	US20110269790 Novel thienopyridines as pharmacologically active agents
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269787 Azabicyclic Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
11/03/2011	US20110269778 Novel diphenyl purine derivatives useful as modulators of nicotinic acetylcholine receptors
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269755 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
11/03/2011	US20110269754 Compounds and compositions for reducing lipid levels
11/03/2011	US20110269752 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
11/03/2011	US20110269750 Roflumilast for the treatment of diabetes mellitus
11/03/2011	US20110269749 Tricyclic carbamate jak inhibitors
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269740 Jak kinase modulating compounds and methods of use thereof
11/03/2011	US20110269738 Compounds
11/03/2011	US20110269736 1,1'-Diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/03/2011	US20110269734 Piperidinyl gpcr agonists
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269711 Methods and compositions for inducing satiety
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269702 Polyacetylenic compounds for protecting against pancreatic islet atrophy
11/03/2011	US20110269700 Glucoside derivatives and uses thereof
11/03/2011	US20110269689 High penetration compositions and their applications
11/03/2011	US20110269680 Glp-1 analogs and uses thereof
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110269678 Nutritional method
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268827 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
11/03/2011	US20110268825 Compositions that include anthocyanidins and methods of use
11/03/2011	US20110268822 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
11/03/2011	US20110268818 Ngal-binding siderophores and use thereof to treat iron deficiency and iron overload
11/03/2011	US20110268811 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
11/03/2011	US20110268795 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes mellitus, prediabetic symptoms, insulin resistance and related disease states and conditions
11/03/2011	US20110268779 Gum compositions
11/03/2011	US20110268770 Chewable gelled emulsions
11/03/2011	US20110268768 Compositions and Methods for Treating Atherosclerosis
11/03/2011	US20110268735 Multimeric constructs
11/03/2011	US20110268730 Method for inhibiting bone resorption
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268721 Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268718 Cactus fruit extract
11/03/2011	US20110268714 CD34 Stem Cell-Related Methods and Compositions
11/03/2011	US20110268713 Variants of Ancestral Uricases and Uses Thereof
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268708 Adipose tissue-derived stem cells for veterinary use
11/03/2011	US20110268702 Lactobacillus paracasei and weight control
11/03/2011	US20110268678 Vitamin d forming sunscreen
11/03/2011	US20110268668 Process for nebulizing aqueous compositions containing highly concentrated insulin
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	DE102010028365A1 Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen Use of a phospholipid-containing composition for removing subcutaneous fat accumulation
11/03/2011	CA2797431A1 Glucagon-like peptide-1 analogue and use thereof
11/03/2011	CA2795543A1 Chemical compounds
11/03/2011	CA2793856A1 Tetrahydrobenzothiophene compound
11/02/2011	EP2383270A1 Piperidine GPCR agonists
11/02/2011	EP2382992A1 Pharmaceutical composition for treating obesity or diabetes
11/02/2011	EP2382984A2 GRF analog compositions and their use
11/02/2011	EP2382974A1 Use of cyclosquaramide compounds as anti-tumour agents
11/02/2011	EP2382204A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
11/02/2011	EP2382203A1 Bicyclic heterocycle derivatives and methods of use thereof
11/02/2011	EP2382202A1 Dihydropyridone amides as p2x7 modulators
11/02/2011	EP2382197A1 Modulators of cystic fibrosis transmembrane conductance regulator
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2382192A2 Dihydropyridone amides useful as medicaments for the treatment of autoimmune and inflammatory diseases
11/02/2011	EP2382012A2 Pharmaceutical compounds
11/02/2011	EP2381938A1 Maintenance fluid for animals
11/02/2011	EP2381796A1 Compositions and methods for treating and preventing weight-related disorders in companion animals
11/02/2011	EP2283008B1 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/02/2011	EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011	EP2114931B1 Piperidine gpcr agonists
11/02/2011	EP2029231B1 Use of alpha-lactalbumin for regulation of glycemia
11/02/2011	EP1960387B1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1535913B1 Novel quaternary ammonium compounds
11/02/2011	EP1386165B1 Inflammatory markers for detection and prevention of diabetes mellitus
11/02/2011	EP1339412B1 Formulation containing phosphate derivatives of electron transfer agents
11/02/2011	EP1011702B1 Stabilized rice bran derivatives for treating diabetes
11/02/2011	CN1981752B Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
11/02/2011	CN102232088A Anti-PCSK9 and methods for treating lipid and cholesterol disorders
11/02/2011	CN102231986A Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome
11/02/2011	CN102231982A Method and composition for use in the treatment or prevention of diabetes
11/02/2011	CN102229668A GLP-1 (glucagon-like peptide-1) derivative and application thereof
11/02/2011	CN102229562A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
11/02/2011	CN102228673A Capsules for treating diabetes and preparation method thereof
11/02/2011	CN102228663A Chinese herbal preparation for adjusting blood fat and controlling fatty liver and hepatocirrhosis
11/02/2011	CN102228657A Enema decoction for treating diabetic nephropathy
11/02/2011	CN102228637A Hpyerglycemic mulberry latex lyophilized powder capsule and preparation method thereof
11/02/2011	CN102228620A Chinese medicinal compound preparation having the functions of supplementing iron and enriching the blood and preparation method thereof
11/02/2011	CN102228589A Chinese herbal composition for treating diabetes
11/02/2011	CN102228577A Traditional Chinese medicine composition for treating hyperlipemia, and preparation method and application thereof
11/02/2011	CN102228574A Preparation method of root of Japanese banana extract and product and application thereof
11/02/2011	CN102228548A Diet pills
11/02/2011	CN102228539A Rosa davurica total flavone extract, its extracting method and its medical use
11/02/2011	CN102228536A Chinese herbal extract for treating diabetic nephropathy and preparation method thereof

1 ... 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 ... 1298